These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37579061)

  • 21. A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.
    DuBiner HB; Mroz M; Shapiro AM; Dirks MS;
    Clin Ther; 2001 Dec; 23(12):1969-83. PubMed ID: 11813932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension.
    Suzuki K; Otsuka N; Hizaki H; Hashimoto M; Kuwayama Y;
    Adv Ther; 2018 Jun; 35(6):796-808. PubMed ID: 29873009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of 0.002% Omidenepag Isopropyl on Intraocular Pressure and the Cornea in Normal Tension Glaucoma.
    Lee SH; Lee WJ; Kim KW; Jeong JH; Park IK; Chun YS
    J Glaucoma; 2023 Apr; 32(4):245-251. PubMed ID: 36729067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys.
    Fuwa M; Toris CB; Fan S; Taniguchi T; Ichikawa M; Odani-Kawabata N; Iwamura R; Yoneda K; Matsugi T; Shams NK; Zhang JZ
    J Ocul Pharmacol Ther; 2018 Sep; 34(7):531-537. PubMed ID: 29989843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.
    Wang K; Xu L; Yuan Z; Yao K; Zhao J; Xu L; Fang A; Zhang M; Wu L; Ji J; Hou J; Liu Q; Sun X
    BMC Ophthalmol; 2014 Feb; 14():21. PubMed ID: 24568617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.
    Chen YY; Wang TH; Liu C; Wu KY; Chiu SL; Simonyi S; Lu DW
    BMC Ophthalmol; 2016 Sep; 16(1):162. PubMed ID: 27633513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periocular Adverse Reactions to Omidenepag Isopropyl.
    Inoue K; Shiokawa M; Katakura S; Tsuruoka M; Kunimatsu-Sanuki S; Shimizu K; Ishida K; Tomita G
    Am J Ophthalmol; 2022 May; 237():114-121. PubMed ID: 34942112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis.
    Li F; Huang W; Zhang X
    Acta Ophthalmol; 2018 May; 96(3):e277-e284. PubMed ID: 29144028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure.
    Denis P; Baudouin C; Bron A; Nordmann JP; Renard JP; Rouland JF; Sellem E; Amrane M
    BMC Ophthalmol; 2010 Feb; 10():4. PubMed ID: 20181282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.
    Fung AT; Reid SE; Jones MP; Healey PR; McCluskey PJ; Craig JC
    Br J Ophthalmol; 2007 Jan; 91(1):62-8. PubMed ID: 16956912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
    Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
    Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
    Kuwayama Y; Hashimoto M; Kakegawa R; Nomura A; Shimada F
    Adv Ther; 2017 Jun; 34(6):1411-1425. PubMed ID: 28502035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silicone punctal plugs as an adjunctive therapy for open-angle glaucoma and ocular hypertension.
    Opitz DL; Tung S; Jang US; Park JJ
    Clin Exp Optom; 2011 Sep; 94(5):438-42. PubMed ID: 21342261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials.
    Wu JH; Chang SN; Nishida T; Kuo BI; Lin JW
    Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):937-948. PubMed ID: 34491427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma.
    Inoue K; Shiokawa M; Kunimatsu-Sanuki S; Kang J; Uraki T; Tomita G; Ishida K
    Jpn J Ophthalmol; 2024 May; 68(3):206-210. PubMed ID: 38587788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line study.
    Crichton AC; Harasymowycz P; Hutnik CM; Behki R; Boucher S; Ibrahim F; Rifkind AW; Solomon L; Liao C; Bastien NR; Sampalis JS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):503-11. PubMed ID: 20874498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial.
    Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G; ; Adeleke M; Ambler G; Barton K; Bourne R; Broadway D; Bunce C; Buszewicz M; Crabb D; Davis A; Garg A; Garway-Heath D; Gazzard G; Hornan D; Hunter R; Jayaram H; Jiang Y; Konstantakopoulou E; Lim S; Liput J; Manners T; Montesano G; Morris S; Nathwani N; Ometto G; Rubin G; Strouthidis N; Vickerstaff V; Wilson S; Wormald R; Wright D; Zhu H
    Ophthalmology; 2020 Apr; 127(4):467-476. PubMed ID: 32005561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.